Phase II trial of cyclophosphamide, vincristine, and dexamethasone in the treatment of androgen-independent prostate carcinoma. Daliani DD, Assikis V, Tu SM, Papandreou CN, Pagliaro LC, Holtkamp T, Wang X, Thall PF, Logothetis CJ, Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX - Cancer 2003;97:561-567

Author： Trump D.L.  

Publisher： Elsevier

ISSN： 1078-1439

Source： Urologic Oncology: Seminars and Original Investigations, Vol.21, Iss.5, 2003-09, pp. : 412-412

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Androgen-independent Prostate Cancer

By Hernes Eivor   Fosså Sophie D.   Skovlund Eva  

Acta Oncologica, Vol. 42, Iss. 7, 2003-11 ,pp. : 749-755

Informa Healthcare

Access to resources Recommend Favorite

Phase I/II trial of high dose mitoxantrone in metastatic breast cancer: the M.D. Anderson Cancer Center experience

By Cristofanilli M.   Holmes F.A.   Esparza L.   Valero V.   Buzdar A.U.   Neidhart J.A.   Hortobagyi G.N.  

Breast Cancer Research and Treatment, Vol. 54, Iss. 3, 1999-04 ,pp. : 225-233

Springer Publishing Company

Access to resources Recommend Favorite

The University of Texas M.D. Anderson Cancer Center Code of Ethics-Revised

By van Eys Jan  

Cancer Prevention International, Vol. 3, Iss. 2, 1998-04 ,pp. : 131-140

Cognizant Communication Corporation

Access to resources Recommend Favorite

Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized, phase II, placebo-controlled trial. Carducci MA, Padley RJ, Breul J, Vogelzang NJ, Zonnenberg BA, Daliani DD, Schulman CC, Nabulsi AA, Humerickhouse RA, Weinberg MA, Schmitt JL, Nelson JB, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD - J Clin Oncol 2003;21:679-689

By Trump D.L.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 5, 2003-09 ,pp. : 410-411

Elsevier

Access to resources Recommend Favorite

A Phase I/II Study of High-Dose Tamoxifen in Combination with Vinblastine in Patients with Androgen-Independent Prostate Cancer

By Hamilton Michael   Dahut William   Brawley Otis   Davis Patricia   Wells-jones Toni   Kohler David   Duray Paul   Liewehr David J.   Lakhani Nehal   Steinberg Seth M.   Figg William D.   Reed Eddie  

Acta Oncologica, Vol. 42, Iss. 3, 2003-01 ,pp. : 195-201

Informa Healthcare

Access to resources Recommend Favorite